Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Acute Antinociceptive Tolerance and Asymmetric Cross-Tolerance between Endomorphin-1 and Endomorphin-2 Given Intracerebroventricularly in the Mouse
2001
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the β2Adrenergic Receptor
2001 StandoutNobel
Descending control of pain
2002 Standout
Cognitive modulation of pain: how do attention and emotion influence pain processing?
2002 Standout
Effect of Chronic Administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone Mesylate (WIN55,212-2) or Δ9-Tetrahydrocannabinol on Cannabinoid Receptor Adaptation in Mice
2002
Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review
2011
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Affinity, potency and efficacy of tramadol and its metabolites at the cloned human µ-opioid receptor
2000
Psychedelics
2016 Standout
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases
2014
Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications
2014 Standout
Social and environmental influences on opioid sensitivity in rats: importance of an opioid’s relative efficacy at the mu-receptor
2005
Complex stimulus properties of LSD: a drug discrimination study with α2-adrenoceptor agonists and antagonists
1995
Endogenous opiates: 1999
2000
Selective attenuation of the antinociceptive effects of μ opioids by the putative dopamine D 3 agonist 7-OH-DPAT
1999
Opioid Tolerance–In Search of the Holy Grail
2002
The Effect of Intrinsic Efficacy on Opioid Tolerance
1995
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Abuse Liability of Prescription Opioids Compared to Heroin in Morphine-Maintained Heroin Abusers
2007
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
Sex Differences in Opioid Analgesia: “From Mouse to Man”
2003
Pharmacological Evidence for a Motivational Role of κ-Opioid Systems in Ethanol Dependence
2007
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy
2006
Agonist‐induced conformational changes in the β2 adrenergic receptor
2002 StandoutNobel
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
2008 Standout
A critical review of the causes of death among post‐mortem toxicological investigations: analysis of 34 buprenorphine‐associated and 35 methadone‐associated deaths
2004
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences
2020 Standout
G‐protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal
2004 StandoutNobel
Role of receptor internalization in the agonist‐induced desensitization of cannabinoid type 1 receptors
2007
Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the µ opioid receptor
2000
Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice
2005
Modulatory effects of dopamine D3/2 agonists on kappa opioid-induced antinociception and diuresis in the rat
2000
Serotonin controlling feeding and satiety
2014
Clinical Pharmacology of Tramadol
2004 Standout
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
2017 Standout
Feelings about food: the ventral tegmental area in food reward and emotional eating
2013
5-Hydroxytryptamine (Serotonin)2A Receptors in Rat Anterior Cingulate Cortex Mediate the Discriminative Stimulus Properties of d-Lysergic Acid Diethylamide
2006
Endocannabinoid-mediated synaptic plasticity and addiction-related behavior
2011
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
2018 Standout
Pertussis: the trials and tribulations of old and new pertussis vaccines
1992
Why sex matters for neuroscience
2006 Standout
μ-Opioid Receptor-Stimulated Guanosine-5′-O-(γ-thio)-triphosphate Binding in Rat Thalamus and Cultured Cell Lines: Signal Transduction Mechanisms Underlying Agonist Efficacy
1997
Reflections on the Efficacy of Pertussis Vaccines
1987
Behavioral pharmacology of buprenorphine, with a focus on preclinical models of reward and addiction
2002
Critical anthropomorphic evaluation and treatment of postoperative pain in rats and mice
2003 StandoutNobel
Neurobiology of addiction: a neurocircuitry analysis
2016 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
1999 StandoutScienceNobel
Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence
2009
An Updated Understanding of the Mechanisms Involved in cHemotherapy-Induced Neuropathy
2018
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
2015 Standout
Carbonic Anhydrase Activators
2018
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Reduction in Opioid- and Cannabinoid-Induced Antinociception in Rhesus Monkeys after Bilateral Lesions of the Amygdaloid Complex
2001
Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspecies
2005 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Hydrogen Sulphide Induces μ Opioid Receptor-Dependent Analgesia in a Rodent Model of Visceral Pain
2010
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
2015 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Hallucinogens
2004 Standout
Pharmacokinetic-Pharmacodynamic Modeling of the Antinociceptive Effects of Main Active Metabolites of Tramadol, (+)-O-Desmethyltramadol and (−)-O-Desmethyltramadol, in Rats
2000
Works of Ellen A. Walker being referenced
Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
1991
In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
1994
Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency.
1993
Naltrexone and β-funaltrexamine antagonism of the antinociceptive and response rate-decreasing effects of morphine, dezocine, and d -propoxyphene
1999
Effects of a Cannabinoid1 Receptor Antagonist and Serotonin2C Receptor Agonist Alone and in Combination on Motivation for Palatable Food: A Dose-Addition Analysis Study in Mice
2008
Selective and nonselective serotonin antagonists block the aversive stimulus properties of MK212 and m-chlorophenylpiperazine (mCPP) in mice
2005
Comparison of Intravenous Buprenorphine and Methadone Self-Administration by Recently Detoxified Heroin-Dependent Individuals
2005
The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse
2009
Slight hyperinsulinaemia but no hypoglycaemia in pertussis patients
1988
Discriminative Stimulus Effects of Nalbuphine in Nontreated and Morphine-Treated Pigeons
1999
Tolerance and cross-tolerance to morphine-like stimulus effects of µ opioids in rats
1997
Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers
2005
Potency Differences ford-Phe-Cys-Tyr-d-Trp-Arg-Thr-Pen-Thr-NH2as an Antagonist of Peptide and Alkaloid μ-Agonists in an Antinociception Assay
2003
The analgesic efficacy of fentanyl: Relationship to tolerance and μ-opioid receptor regulation
2008
Differential tolerance to antinociceptive effects of µ opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats
2001
Clocinnamox Antagonism of the Antinociceptive Effects of Mu Opioids in Squirrel Monkeys
1998
Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
1991
Whooping cough in Glasgow 1969-80
1981
Cannabidiol inhibits paclitaxel‐induced neuropathic pain through 5‐HT1A receptors without diminishing nervous system function or chemotherapy efficacy
2013
Opioid receptors and acetaminophen (paracetamol)
2004
Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure.
1995
Single and combined effects of Δ9‐tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy‐induced neuropathic pain
2017
In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
1994
Ethylene bis-imidazoles are highly potent and selective activators for isozymes VA and VII of carbonic anhydrase, with a potential nootropic effect
2014
Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine.
1993